Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

: Comi G, O'Connor P, Montalban X, Antel J, Radue E W, Karlsson G, Pohlmann H, Aradhye S, Kappos L, FTY720D2201 Study Group

: 2010

: Multiple Sclerosis

: 2

: 16

: 2

: 197

: 207

: 11

: 1352-4585

DOI: https://doi.org/10.1177/1352458509357065